Less Cost and Less Hypoglycemia with Insulin Pens over Syringe and Vials

The study showed that the insulin pen had lower costs than the insulin aspart vial/syringe (n=9305; 62.7%-89%). The insulin aspart pen was also associated with fewer hypoglycemic episodes than the insulin aspart vial/syringe (35%-44%). Current Medical Research & Opinion